Back to results
US 2008/0188515 A1Published application
Imidazo [1,2-A] Pyridine Derivatives Useful As Peptide Deformylase (Pdf) Inhibitors
AssigneeNovartis AG
InventorMichael Thormann
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I). These compounds are a novel type of peptide deformylase (PDF) inhibitors, and are therefore of great interest especially as new antibiotics.
Claims16
Compounds of formula (I)
- worin
- the radicals R1, R2, R3 and R4, independently of one another, are a hydrogen atom, a halogen atom, a hydroxy, amino, nitro or thiole group, an alkyl, alkenyl, alkinyt, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, hetero-alkylcycloalkyl, heterocycloalkyl, aralkyl or a heteroaralkyl radical, whereby all of these radicals may optionally be substituted, or two of the radicals R1, R2, R3 and R4 together may be part of a cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring, whereby each of these rings may optionally be substituted;
- R5 is a hydrogen atom, a halogen atom, a hydroxy, amino, nitro or thiole group, an alkyl, alkenyl, alkinyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or heteroaralkyl radical;
- the radicals R6 and R7, independently of one another, are a hydrogen atom, or an alkyl, alkenyl, alkinyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or heteroaralkyl radical, whereby all these radicals may optionally be substituted;
- and
- X is a group of formula —CS—NHOH, —CH2—CO—CH2—OH, —CO—CH2—OH, —CO—NHOH, —CNH—NHOH, —CH2—NOH—CHS, —NOH—CHS, —NOH—CHO, —CH2—NOH—CHO, —CH2—CHOH—CHO, —CHOH—CHO, —CHOH—COOH, —CH(CH2—OH)—COOH, —COOH or —CH2COOH, or is selected from the following formulae:
- whereby U is a bond, CH2, NH, O or S, V is O, S, NH or CH2, W is O, S, NH or CH2, and Y is OH or NH2, E is a bond, CH2, NH, O or S and the groups D, G and M, independently of one another, are N or CH, or a pharmaceutically acceptable salt, solvate, hydrate or a pharmaceutically acceptable formulation thereof.
4 more elements
Dependencies are inferred from the claim text.